McGovern resident selected in Young Investigator Draft
Football fans know the feeling all too well: On draft day, April 23, the commissioner of the National Football League will walk on stage and announce a team is on the clock. As the seconds tick away, team executives make decisions that will shape the future of their respective franchises.
Thanks to Uplifting Athletes, a nonprofit that connects student-athletes and professional athlete ambassadors with local rare disease communities, young researchers like Sunanjay Bajaj, MD, a resident in the Department of Neurology at McGovern Medical School at UTHealth Houston, are experiencing a version of that moment.
Inspired by the NFL draft, the Young Investigator Draft shifts the spotlight from football prospects to the next generation of promising medical researchers focused on rare diseases. The initiative is one of several created by Uplifting Athletes to raise awareness and research funding for rare diseases, which affect an estimated 30 million people in the United States.
Bajaj is one of 10 recipients of a $20,000 grant through the program. The funding supports research aimed at bridging developmental neuroscience with translational applications for rare diseases. Working in the lab of Dennis Lal, PhD, associate professor in the Department of Neurology, Bajaj collaborates with patients, families, and rare disease foundations to develop quantitative, clinically meaningful approaches to phenotype characterization.
Born and raised in Kathmandu, Nepal, Bajaj was first introduced to the scientific foundations of neurodevelopmental disorders at his alma mater, the University of Heidelberg. He later completed a research doctorate at the Vienna BioCenter, where his work on interneuron migration in brain organoids deepened his interest in neuroscience and guided him toward clinical neurology. He moved to the United States in 2023 to begin residency training at UTHealth Houston, with the goal of building a translational research career focused on rare neurodevelopmental disorders.
The Young Investigator Draft reflects Uplifting Athletes’ ongoing commitment to accelerating scientific progress in rare disease treatments and potential cures while supporting the next generation of researchers.
Grants awarded through the program fund basic research with the goal of advancing treatments and potential cures for the broader rare disease community. Over nearly a decade, Uplifting Athletes has provided almost $1.5 million in funding to 75 rare disease researchers.
Submissions for the Young Investigator Draft are evaluated by an expert panel of scientific advisers before each year’s class is selected. Each researcher is nominated by a patient advocacy organization recognized by Uplifting Athletes as a priority partner. Bajaj was nominated by the CSNK2A1 Foundation.